Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

281/19 – Future Gaming Group International AB is moved to the Observation List

Following today’s press release from Spotlight, the company’s share will be moved to Spotlight’s Observation List.Information about the share:  Shortname: FGG ISIN-code: SE0002209155 Orderbook-ID: 410Q CFI: ESVUFR FISN: FUTUREGAMI/SH Organization number: 556706-8720 LEI: 549300L39DAQ4PEVZX44  Stockholm October 30, 2019  Spotlight Stock Market 08-511 68 000    trading@spotlightstockmarket.com

ÅF Pöyry wins major order from Chr. Hansen in Denmark

ÅF Pöyry has signed a new contract with the bioscience company Chr. Hansen A/S.ÅF Pöyry will modernize Chr. Hansen’s production plant in Roskilde, Denmark. The order is an end-to-end solution. The plant in Roskilde produces probiotics used in food and pharmaceutical industries. The contract covers an upgrade of the interfacing units to support earlier delivered fermentation line to reach higher capacity. ÅF Pöyry is responsible for project management, process and electrical design, installation, commissioning and qualification of all necessary components “With new modern production

Roofit.solar named Swedish Steel Prize 2019 finalist

For developing an innovative roofing product that successfully combines a highly effective solar panel with an architecturally attractive and environmentally friendly steel roof, Roofit.solar has been nominated for the Swedish Steel Prize 2019. The Swedish Steel Prize, which celebrates its 20th anniversary this year, aims to recognize the good engineering, cooperation and steel innovations that lead to a better and more sustainable world. Roofit.solar, from Estonia, is one of the four finalists for this year’s prize, which will be awarded during a ceremony in Stockholm, Sweden on

New date for the release of Interim report January – September 2019

The date for the release of Cabonline Group Holding AB (publ) Interim report January – September 2019 has been changed to an earlier date November 4, 2019 at 08:00 CET.For information:Johan Ryrberg, acting CFO tel +46 70 538 76 70 About Cabonline GroupCabonline Group is a leading technology and service provider for the taxi industry in the Nordics. In Sweden, Finland, Norway and Denmark, around 3,000 transporters are connected with approximately 5,700 vehicles under different brands, including TaxiKurir, Norgestaxi, TOPCAB, Kovanen, Taxi Skåne, Taxi Väst, Umeå Taxi, Sverigetaxi and

Publishing of Apetit Plc’s Business Review for January-September 2019

Apetit Plc, Investor News, 30 October 2019 at 10:00 a.m.Apetit Plc will publish its Business Review for January-September on Wednesday 6 November 2019 at 8.30 am. A separate press conference in relation to the Business Review will not be arranged.Apetit PlcFor further information, please contact:Sanna Väisänen, Director, Corporate Communications and Sustainability, tel. +358 10 402 4041Apetit is number one in vegetables. It is a food industry company firmly rooted in Finnish primary production. We create well-being with vegetables by offering healthy and tasty food solutions that

NENT Group expands RiksTV distribution partnership in Norway

· Viaplay to be available as part of RiksTV’s Strim streaming offering   · NENT Group’s Norwegian TV channels continue to be available through RiksTV · Partnership reflects NENT Group’s unique content offering and strategic focus on long-term distribution deals Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, and Norwegian TV operator RiksTV have agreed an extended long-term distribution deal that brings NENT Group’s Viaplay streaming service and TV channels to more viewers in Norway than ever before. Starting autumn 2019, Viaplay will be

AHTS contracts awarded by INPEX

Solstad Offshore ASA (“Solstad”) has entered into a contract with Inpex Operations Australia Pty for the provision of two anchor handlers to support additional drilling for the Ichthys LNG development. Normand Scorpion and Normand Sirius will be contracted to INPEX for a period of 3 years. The anchor handlers are expected to mobilise out of Broome, Australia in the first quarter of 2020.  “We are delighted to receive this contract award from INPEX.  This is a continuation of earlier support provided to the Ichthys LNG development and we relish the opportunity to continue our

Carbiotix to conduct internal pilot study of gut health testing services with Gebro Pharma AG Switzerland

Carbiotix AB (publ) ("Carbiotix") announces today that the company will conduct an internal pilot study of its gut health testing services with Gebro Pharma AG Switzerland. The pilot study is planned for Q1 2020 and will serve to formulate a business model for a new collaborative service and roll out plan for 2021.Gebro Pharma AG Switzerland is a subsidiary of Gebro Pharma (www.gebro.com/en/), a privately held Austrian company focusing on the development, manufacturing and sale of medicinal products in 25 countries. Gebro Pharma AG Switzerland is located in Liestal, near the city of Basel,

Tethys Oil farms into Block 56 Exploration and Production license onshore Oman

Tethys Oil AB, through its wholly owned subsidiary Tethys Oil Oman Onshore Limited (“Tethys Oil”), has entered into an agreement with Biyaq Oil Field Services (“Biyaq”) to acquire a 20 percent interest in the Exploration and Production license covering Block 56 onshore Oman. The transaction is subject to Government approval.Block 56 (the “Block”) covers an area of 5,808 km2 in the south-eastern part of Oman some 200 km south of Blocks 3&4. To date 11 wells have been drilled on the Block and all but one have encountered oil or oil shows, although none have been determined to be commercial.

LeoVegas to sell subsidiary Authentic Gaming

LeoVegas has entered into an agreement to sell its subsidiary Authentic Gaming to Genting. The sales price is EUR 15 m on a debt-free basis and represents a return of more than 100% during a slightly more than three-year period.Authentic Gaming has developed into a profitable company with a prominent position in its niche in the live casino market. Genting, with over 50,000 employees, is one of the world’s largest groups in land-based casino with a rapidly growing digital business arm. Authentic Gaming is one of three holdings included in LeoVentures, the LeoVegas Group’s investment company

Medivir presents MIV-818 data at AACR-NCI-EORTC in Boston

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that a poster entitled “MIV-818 stimulates an anti-tumor immune response in vitro and enhances the effects of pembrolizumab” was presented at the AACR-NCI-EORTC conference in Boston. The data shows that MIV-818 exerts favorable immunomodulating effects in vitro by increasing immune cytokine levels in complex tumor microenvironment models, and the white blood cell mediated killing of cancer cells. These effects are further enhanced in combination with the anti-PD1 check-point inhibitor pembrolizumab. “It is exciting

Redeye initiates analyst coverage of Toadman Interactive AB (publ)

Toadman Interactive AB (publ) has entered into an agreement with Redeye concerning analyst coverage. Redeye offers a paid service, where Toadman pays Redeye for the coverage. Redeye’s initiating coverage will be released to the market following Toadman’s Q3 2019 report scheduled for 26 November 2019.   FOR FURTHER INFORMATION, PLEASE CONTACT: Robin Flodin, CEO Phone: +46 70 477 06 34 robin@thetoadman.com   ABOUT TOADMAN Toadman Interactive AB (Publ) (“Toadman”) develops and markets PC, console and mobile games for the global games market. The Group’s Game

AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia

30 October 2019 07:00 GMT AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia Sale to Cheplapharm supports AstraZeneca's focus on main therapy areas AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe and Russia to Cheplapharm Arzneimittel GmbH (Cheplapharm). Seroquel and Seroquel XR, used primarily to treat schizophrenia and bipolar disorder, have lost their compound patent protection in Europe and Russia. Ruud Dobber,

BONESUPPORT HOLDING AB (publ) – Q3 2019 Interim Report – invitation to conference call and webcast

Lund, Sweden, 08.00 am CET, 30 October 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids, will publish its Q3 2019 interim report on the 7 November 2019 at 08.00 am CET. The Company will hold a conference call and an online presentation on the same day at 10.00 am CET. The call will be hosted by Emil Billbäck, CEO and Håkan Johansson, CFO who will present the results and answer questions. The presentation will be held in English. The dial-in numbers for the conference call are: UK: + 44 333 300 92 71 SE: + 46 8 505 583 51

Interim report January-September 2019

July-September 2019 · Net sales were 321.9 MSEK (265.4), an increase of 21.3% from the equivalent quarter in 2018. · Operating income increased to 31.4 MSEK (26.7), an operating margin of 9.8% (10.1). In the equivalent quarter in 2018 there were one off costs of 3.5 MSEK. · The acquired business Hotbath contributed 61.2 MSEK to net sales and 10.6 MSEK to operating profit after amortisation of intangible assets.   · Earnings per share were 1.77 SEK (1.49). · Cash flow after investments was 47.8 MSEK (44.5). January-September 2019 · Net sales were 969.4 MSEK (859.0),

Exel Composites Plc’s January – September Business Review 2019: “Strong improvement in profitability”

EXEL COMPOSITES PLC     STOCK EXCHANGE RELEASE    30 OCTOBER 2019 at 09:00 EETQ3 2019 in brief ·  Order intake increased by 9.7% to EUR 27.1 million (Q3 2018: 24.7). ·  Revenue increased by 2.3% to EUR 23.6 million (23.1). ·  Adjusted operating profit increased to EUR 1.7 million (0.5), representing 7.0% of revenue (2.1). ·  Operating profit increased to EUR 1.5 million (0.5), representing 6.2% of revenue (2.0). ·  Net cash flow from operating activities was EUR 1.7 million (1.6). ·  Earnings per share amounted to EUR 0.07 (0.00). Q1-Q3 2019 in brief ·  Order

Beactica Therapeutics participates in innovative training network on targeted protein degradation

PRESS RELEASE Uppsala, Sweden – 30 October 2019Beactica Therapeutics, the Swedish drug discovery company, today announced its participation in a Marie Skłodowska-Curie Innovative Training Network (ITN) called UbiMotif. The ITN is funded with EUR 4.1 million under the European Commission's Horizon 2020 programme and aims to deliver 15 skilled early-stage researchers in the area of targeted protein degradation, an emerging field predicted to revolutionize how “undruggable” proteins can be targeted in diseases such as cancer and neurodegeneration. UbiMotif will focus on identification,

Veidekke ASA: Stable building construction market expected going forward

At the start of a new decade, the Scandinavian building construction market looks more stable than for many years. Veidekke expects steady, relatively high activity in Scandinavia in 2020.For the time being, the highly cyclical housing market appears to be past the largest fluctuations. “Most major metropolitan areas are experiencing moderate price growth and a high number of transactions in the secondhand housing market. However, the number of new home sales is also rising steadily, and national statistics bureaus are reporting a tapering off of construction costs,” says Veidekke

Gaming Innovation Group: Invitation to Q3 2019 results presentation

Gaming Innovation Group Inc. (GiG) publishes its interim report for the third quarter (July - September) 2019 before market opening on Wednesday 6 November 2019. Acting CEO Richard Brown will present the Q3 results at 10:00 CET at Helio GT 30, Grev Turegatan 30, Stockholm. The presentation will be given in English and available live via webcast and via a telephone link. Questions can be asked via the weblink. Link to the webcast: https://tv.streamfabriken.com/gig-q3-2019 Dial-in numbers for participation in the telephone conference: Norway: +4723500236 Sweden: +46856642703

PARETO ADVISES SSG BIDCO ON THE SUCCESSFUL PLACEMENT OF A EUR 50 MILLION SENIOR SECURED BOND

Pareto Securities AB has advised BidCo af 28.04.2017 A/S (“SSG BidCo” or the “Issuer”), ultimately owned by the Nordic private equity firm Polaris, on its successful placement of a 5-year initial EUR 50 million senior secured bond (the “Bonds”). The Bonds, maturing in 2024, will carry a floating rate coupon of 3 month EURIBOR + 6.00 per cent, with interest paid quarterly. The Bonds will be governed by Swedish law and the Issuer has undertaken to list the Bonds on a regulated market. The proceeds from the bond issue will be applied towards the acquisition of SSG Partners A/S (“SSG”) from

Q-linea receives positive response from the FDA for the design of the company's planned clinical study in the USA

Q-linea AB (publ) (OMX: QLINEA, announced today that the company has received the official response including a number of clarifications and very positive feedback from the US Food and Drug Administration, FDA, regarding the company's planned pivotal clinical trial with ASTar® in the United States.“We are very pleased with the official feedback from the FDA which will have a very positive impact on the conduct of our clinical study in the US. We have received the clear guidance we wanted and we believe that the study can be carried out in a more straightforward way than previously estimated,

Interim report for BEWiSynbra Group for the period January to September 2019

HIGHLIGHTS for 2019 Numbers in parentheses refers to the corresponding periods in the previous year Third quarter · BEWiSynbra Group reported net sales of SEK 1,145.8 million for the third quarter (SEK 1,160.2 million), a decrease of 1.2 per cent compared to the corresponding quarter last year · Adjusted EBITDA was SEK 137.2 million (SEK 98.3 million), while adjusted EBITA amounted to SEK 84.3 million (SEK 65.3 million) · Earnings were negatively impacted by items affecting comparability of SEK 5.6 million for the quarter (negatively impacted by SEK 20.1 million) · EBIT

Invitation to presentation of Balco’s third quarter report 2019

Växjö, 30 October 2019 Balco’s interim report for the third quarter 2019 will be published at 07:30 CET on November 14, 2019. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the third quarter 2019. A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, www.balcogroup.se or via the following link https://tv.

SCA Interim Report Q3 2019

JANUARY 1 – SEPTEMBER 30, 2019(compared with January 1 – September 30, 2018) · Net sales increased 10% to SEK 15,279m (13,829), mainly related to higher delivery volumes due to the continued ramp-up of the expanded Östrand pulp mill · EBITDA increased 13% to SEK 4,264m (3,758). The improvement was mainly related to higher delivery volumes from the expanded Östrand pulp mill and positive exchange rate effects, which was offset by lower selling prices. · EBITDA margin was 27.9% (27.2) · Operating cash flow increased to SEK 2,339m (2,007) · Earnings per share amounted to SEK

There are no items matching the current filter
There are no more items matching the current filter
Back to top